A new series of triazolo[4,3-a]pyimidine derivatives via solid phase multicomponent reaction between 3-oxo-N-(4-(3-oxomorpholino)-
phenyl)butanamide, aromatic aldehyde and aminoazole is reported. All the synthesized compounds have been characterized by elemental
analysis and spectral analyses. Moreover, the synthesized compounds were also screened for their antibacterial activity against
Staphylococcus aureus MTCC-96, Escherichia coli MTCC-443, Bacillus subtilis MTCC-441, Pseudomonas aeruginosa MTCC 1688,
and antifungal activity against Aspergillus niger MTCC-282 and Penicillium sp. at different concentration and compared with standards
drugs. The minimum inhibition concentration (MIC) of the compounds was studied by micro-broth dilution method.
一种新的三唑并[4,3-a]
吡咪啉衍
生物系列通过固相多组分反应合成,反应物包括3-氧代-N-(4-(3-氧代吗啉基)-苯基)丁酰胺、芳香醛和
氨基唑。所有合成的化合物均经过元素分析和光谱分析进行表征。此外,合成的化合物还被筛选其抗菌活性,包括对
金黄色葡萄球菌M
TCC-96、大肠杆菌M
TCC-443、
枯草芽孢杆菌M
TCC-441、
铜绿假单胞菌M
TCC 1688的抗菌活性,以及对黑曲霉M
TCC-282和青霉菌的抗真菌活性,浓度不同,并与标准药物进行比较。化合物的最小抑制浓度(MIC)通过微量稀释法进行研究。